logo

For the Inventor, By the Inventor

Basel, Switzerland

Beigene Switzerland Gmbh


USPTO Granted Patents = 22

% Expired Patents = 4.5


Trademarks = 4

Forward Citations = 112

Loading Chart...
Loading Chart...

33 inventors (with patents filed for the assignee):

goldMedal Zhiwei Wang (11 out of 80 patents)

silverMedal Yunhang Guo (11 out of 25 patents)

bronzeMedal Gongyin Shi (8 out of 8 patents)

4.  Tong Zhang (7 out of 88 patents)

5.  Kang Li (7 out of 32 patents)

6.  Jing Song (6 out of 15 patents)

7.  Qi Liu (5 out of 103 patents)

8.  Lai Wang (5 out of 8 patents)

9.  Hao Peng (4 out of 11 patents)

10.  Lanlan Xu (4 out of 7 patents)

11.  Min Wei (3 out of 15 patents)

12.  Jason Paik (3 out of 3 patents)

13.  Ying Ou (3 out of 3 patents)

14.  Tommi Salmi (3 out of 3 patents)

15.  Lusong Luo (2 out of 4 patents)


22 patents:

1. 12234286 - Anti-TIGIT antibodies and their use as therapeutics and diagnostics (2025-02-25),
2. 12233069 - Oral solid tablet comprising Bruton's Tyrosine Kinase inhibitor and preparation method therefor (2025-02-25),
3. 12103931 - Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof (2024-10-01),
4. 11999743 - Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof (2024-06-04),
5. 11970500 - Crystalline form of (s)-7-(1-acryloylpiperidin-4-yl)- 2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof (2024-04-30),
6. 11911386 - Methods of treating B-cell proliferative disorder (2024-02-27),
7. 11896596 - Methods of treating B-cell proliferative disorder (2024-02-13),
8. 11884674 - Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof (2024-01-30),
9. 11851437 - Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof (2023-12-26),
10. 11814389 - Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof (2023-11-14),
11. 11786531 - Methods of treating B-cell proliferative disorder (2023-10-17),
12. 11786529 - Treatment of indolent or aggressive B-cell lymphomas using a combination comprising BTK inhibitors (2023-10-17),
13. 11701357 - Treatment of B cell cancers using a combination comprising Btk inhibitors (2023-07-18),
14. 11673951 - Anti-PD1 antibodies and their use as therapeutics and diagnostics (2023-06-13),
15. 11591340 - Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof (2023-02-28),
Company Overview
Beigene Switzerland GmbH is a biopharmaceutical company based in Basel, Switzerland, specializing in the development and commercialization of innovative cancer therapies. The organization focuses on advancing treatments that target specific genetic mutations and pathways, aiming to improve patient outcomes in oncology. With a commitment to research and development, Beigene leverages cutting-edge technologies to create effective solutions for complex cancer challenges, contributing to the global fight against cancer.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

22 Patents

#26 in Basel

#574 in Switzerland

#28,782 in the World

Basel, CH
Basel, Switzerland

Beigene Switzerland Gmbh

Forward Citations = 112

33 inventors:

goldMedal Zhiwei Wang (11 out of 80 patents)

silverMedal Yunhang Guo (11 out of 25 patents)

bronzeMedal Gongyin Shi (8 out of 8 patents)

4.  Tong Zhang (7 out of 88 patents)

5.  Kang Li (7 out of 32 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Beigene Switzerland Gmbh. Retrieved from https://idiyas.com/company/beigene-switzerland

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…